µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º }[>RxHd
[Krm .)
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ z'?7]C2b
+=ZWau
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) RNv{n
mf
U6c)"^\
1. ICAM-1 &Pu+(~'Q
5nM kd/
2. interleukin 12(IL-12) l5FuMk-
B;xZ%M]
3. tumor infiltrating lymphocyte W<\ kf4Y
Zg)_cRR
4. TCR/CD3 complex `Mg8]H~
QuSV&>T\
5. hematopoietin receptor family ad"'O]
p&i.)/
6. individual idiotype(IdI) Ho|o,XvLv
Wyy^gJ
l
7. integrin lq:]`l,6@
c:=7lI
8. colony-stimulatory factor (CSF) 8h*t55
<_"B}c/2$
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© 9Hu
d|n
ypH8QfxLTr
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? *dN N<
uaiz*Im
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ S"zk!2@C
E(_KN[}S
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ(/&;jV2DD[
7skljw(
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ Z(p*Z,?u
?{eY\I
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) R<|ejw
0E-pA3M6
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ \^9pW 2v
:/6()_>bO
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) RAV^D.
'99@=3AB:`
3. immunoglobulin superfamily (IgSF) _
%{0?|=
bG(x:Py&
4. selectin 4@6<
jJia.#.Ze
5. anti-idiotypic antibody (¦ÁId) LKx` v90p
.#0H{mk
6. major histocompatibility complex(MHC) mZ7B<F[qV
96=Z"
7. immunotolerance 3C M^j<9
1[ SA15h
8. biological reponse modifier(BRM) (9]6bd
(~&w-w3
9. immune reponse gene (Ir gene) J=iRul^S
d; =u
10. reshaped antibody (or reconstituted antibody) RBE7485
pDn&V
(
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© uE`r /=4
_R^y\1Qu
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ T@P!L
>b48>@~bY
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? t'g^W
JoJukoy}F
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ s8vKKvs`9
SkHYXe"]
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? #{*LvI&
E'EcP4eL
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ ar$*a>'?
=45W\
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? | -+zofx
]Blf9h7
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ 2*2:-ocl$
L:@fP~Erh
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ opp!0:jS*
sgAzL
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? +,5-qm)Gh>
UyiJU~r1
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ u9Y3?j,oC
%8r/oS
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: .L EY=j!-s
~OypE4./1
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ;Vu5p#,O<M
(9C<K<
̉񧄤 :iPym}CE
2k5/SV
X
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© }
]6f+
qCPmbg
1. CD8 Q(Gl{#b
GF$`BGW
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) Or0O/\D)
EWjgI_-
3. immunoglobulin fold(Ig fold) t ^SzqB
_ZY\,_
4. cadherin (Ca-dependent cell adhesion moleculers) !3qVB
e0HfP v_
5. idiotype-anti-idiotypic antibody immune network theory v)X\GmW7w
*d*,Hqn
6. HLA class II antigen _NZ@4+aW
p/GVTf
7. complementarity-determining region (CDR) e' 9r"<>i
"TOa=Tt{,
8. perforin(or pore-forming protein ,PFP) {XCf-{a]~
v&
$k9)]
9. high affinity IL-2 receptor ,5Vt]#F5@
r'7LR
10. artificial active immunization j2 %^qL
pY"O9x
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© >SbK.Q@ei
]
d}0l6
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦ÓᣠjeUUa-zR3
S.*~C0"
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 }hpmO-
4=8QZf0\
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ {Qu"%h.Al
yHo[{,4itA
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ $A_]:qI2
@~td`Z?1y
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ 5s{j=.O
SkQswH
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? Dh4
6o|P
$FTO
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ bC!`@/
B=f,QU
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ ,MPB/j^o5!
R\3VB NX.g
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ
dq;|?ESP
OHrY(I6
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ g`^X#-!(
&C<yfRDu
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© VSX@e|Nj
] ]U<UJ
1. immunoglobulin gene rearrangement =<@2#E)
:(|'S4z
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) z+}QZ>
B<?[Mrdxw
3. flow cytometry(FCM) .R*!aK
O) |P,?
4. carrier effect J@pb[O L,
sb_oD{+gW
5. positive selection of T lymphocytes in thymus lH^^77"4Qo
DhLqhME53
6. mouse TH1(Th1) and TH2(Th2) subsets
\`<cH#
[D"t~QMr
7. perforin (pore-forming protein ,PFP) pL=d% m.W
gF=jf2{YX
8. ADCC(antibody-dependent cell-mediated cytotoxicity) ^efb
5
^mWybPqx
9. SH-2(src-homology region 2) WW2
Ob*
JCcZuwu[
10. Ab2¦Â (internal image) YYEJph@06q
WO4=Mte?
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© c
}*2$1
-4rDbDsr
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? c3*t_!@oC
,B(7\
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? >h2%[j=
87%*+n:?*
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ8[CB>-9
*%w69#D
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ Z@8vL
.x`M<L#M(
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦Óᣠ?&LZB}1
R
_zt19%Wg
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) k%wn0Erd
IKtB;
ÃâÒßѧרҵ£º n?\ nn3
)b<k#(i@#
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ \\BCcr\l
F62V3 Xy
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? y-p70.'{U
d_n7k
g+
´«È¾²¡Ñ§×¨Òµ£º w{~+EolK
~^u16z,
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ 1Gt/Tq$_b
I/VxZ8T
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ lnovykR
*`j-i
Ïû»¯×¨Òµ£º }?cGf-c
<9=9b_z
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ /&u<TJ4
0JgL2ayIVI
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? )!g{Sbl
hS[yNwD
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ 2^t#6XBk/
;})5:\h
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© JKer//ng4
<<D$+@wxm
1. Fas(CD95)/FasL c4_`Ew^k
st"{M\.p
2. common chain of cytokine receptor _#$*y
#j@71]GI
3 . TCR/CD3 complex 2tROT][J%
Xtwun
4. negaive selection of thymocytes =9kN
_:-
?ER-25S
5. artificial active immune ,!V]
jP)
J$~<V
IX
6. anti-idiotypic BmHwu{n'
+(uYwdcN
7. IgSF 0!z@2[Pe66
p3/*fH98
8. Integrin $3Z-)m
DK0.R]&4(
9. chemokine 0
ugT2%
IVlf=k
10. B7/CD28 [~:-&
i{D=l7j|w
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© jGrN\D?h
dD<fn9t
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ v^ d]rSm
"RVcA",
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ OT^%3:zg
*5<Sr q'
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ '8Phxx|
A]L%dFK
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ %+ZJhHT
m\/ Tj0e
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ a?yMHb{F
^IKO2Ft
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ p0.|<
CIjZG ?A
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© )} DUMq7
oJKa"H-jL
1. B7/CD28 /v095H@
A?TBtAe
2. Th1 subset PX|=(:(k
EkT."K
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© g~UUP4<$"
yGg,$WM
4. antibody affinity maturation I2(zxq&2M\
d2X
[(3
5. AP-1 nS()u}c;r
Hn,:`mj4-6
6. single chain variable fragment£¨ScFv£© tU"raP^=
{%w!
@-
7. NK cell receptor Oo?,fw
D[O{(<9
8. Zinkernagel-Doherty phenomenon UEak^Mm;=2
i?Ss: v^
9. Ig fold > Oh?%%6
#6Xs.*b5C
10. CD40/CD40L Qy#)Gxp
\qi|Js*{
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© qDWsvx]
S{',QO*D6
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ _<ut)
G^9
NGYyn`Lx
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ \EbbkN:D
s!/TU
{8J
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ ctQbp~-
3+MB5T
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ S)He$B$pp
9^P2I)aD
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ Do?P<x o
\^*<
y-jL
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ <